News Headlines Article

Controversial young blood transfusions startup is trying to resume operations again
San Francisco Business Times

A controversial startup that buys blood plasma from young people and pumps it into the veins of older people is talking with the U.S. Food and Drug Administration about resuming operations, the company now says online.

The company, which was founded by a Stanford Medical School graduate, this week told a potential customer that it was currently operating in two cities‚ San Francisco and Tampa, Florida, according to a reporter at Business Insider who viewed the email and first reported on the company’s attempts to restart operations.

In mid-February, FDA regulators issued a public warning against voluntary transfusions. And although it didn’t explicitly name Ambrosia Health, the company that week said it was voluntarily halting treatments.